Epidemiology of Immune-Mediated Inflammatory Diseases: Incidence, Prevalence, Natural History, and Comorbidities

Epidemiology of Immune-Mediated Inflammatory Diseases: Incidence, Prevalence, Natural History, and Comorbidities
复制标题

DOI:
10.3899/jrheum.091461
复制
发表时间:
2010-05-01
影响因子:
3.9
通讯作者:
Bernstein, Charles N.
Bernstein, Charles N.
中科院分区:
医学2区
文献类型:
--
作者:
El-Gabalawy, Hani;Guenther, Lyn C.;Bernstein, Charles N.

文献摘要

被引文献

相似文献

免疫介导的炎症性疾病 (IMID) 是一组常见且高度致残的慢性疾病,它们具有共同的炎症途径。过去几十年来,多项 IMID 发病率和患病率研究报告称,不同人群中该疾病的发生率存在相当大的差异。总体而言,西方社会IMID的患病率估计为5%-7%。本文概述了 IMID 的发病率、患病率、自然史和合并症的研究。 (J Rheumatol 2010;37 Suppl 85:2-10;doi:10.3899/jrheum.091461)
Immune-mediated inflammatory diseases (IMID) present a group of common and highly disabling chronic conditions that share inflammatory pathways. Several incidence and prevalence studies of IMID during the past decades have reported a considerable variation of the disease occurrence among different populations. Overall, the estimated prevalence of IMID in Western society is 5%-7%. This article provides an overview of studies of the incidence, prevalence, natural history, and comorbidities of IMID. (J Rheumatol 2010;37 Suppl 85:2-10; doi:10.3899/jrheum.091461)